Xcout Intel
iOnctura
iOnctura is headquartered in Geneva, Switzerland, with research operations in Amsterdam, developing targeted cancer therapeutics.
Subscribe to see iOnctura’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
iOnctura at a glance
iOnctura is a healthcare company headquartered in Switzerland. It has raised at least $107.7M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $86M in June 2024. Xcout tracks 13 named people at iOnctura, including Michelle Tsai (COO).
iOnctura leadership
- Michelle TsaiCOO
- Steven SciutoCFO
- Mark VellecaChair
- Elizabeth HoltCBO
- Michael LahnCMO
- Catherine PickeringCo-Founder, CEO
7 more named people on record for iOnctura, with roles, board committees and tenure — see the full roster →
iOnctura funding rounds
At least $107.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $86M | 4 named | |
| Series A | $21.6M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
iOnctura competitors
A few of iOnctura's closest competitors — see the full list of competitors and alternatives →
ACEA Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel medicines to improve the lives of patients with chronic and life-threatening diseases. The company focuses on oncology and targeted therapies through rigorous clinical research. Its global headquarters is located in San Diego, California, United States.
HiberCell is a clinical-stage oncology company headquartered in New York, New York, with additional locations such as Roseville, Minnesota. It focuses on the discovery and development of therapeutics targeting cancer recurrence and resistance.
Eigen Therapeutics is a biotechnology company headquartered in Redwood City, California, focused on developing 'priming' therapies that make cancer easier to find and eliminate.
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
Sprint Bioscience is a pharmaceutical company that develops innovative preclinical drug candidates for cancer treatments. Utilizing a fragment-based drug discovery method, the company creates and out-licenses its drug programs to global pharmaceutical partners.
Inthera Bioscience AG is a Swiss biotechnology company focused on the discovery and development of targeted small molecule therapies, including modulators of intracellular protein-protein interactions, for the treatment of solid tumors. Headquartered in Zurich, the private company's pipeline features assets such as its lead oral small molecule candidate, INTH-454.
Get iOnctura's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on iOnctura in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access